Literature DB >> 2529807

Pyridoxine for the palmar-plantar erythrodysesthesia syndrome.

S J Vukelja, F A Lombardo, W D James, R B Weiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2529807     DOI： 10.7326/0003-4819-111-8-688

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer.

Authors:  F G Jansman; D T Sleijfer; J C de Graaf; J L Coenen; J R Brouwers
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Cutaneous Toxicity in a Laboratory Beagle (Canis lupus familiaris) after Chronic Administration of Doxorubicin Hydrochloride.

Authors:  Kathryn A Guerriero; Steven R Wilson; Nabil E Boutagy; Chi Liu; Albert J Sinusas; Caroline J Zeiss
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

3.  Cutaneous toxicity of oral low-dose methotrexate.

Authors:  Priyanka Jalandhara; Gurjit Kaeley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-22

4.  Long-term sequelae of Palmar-Plantar erythrodysaesthesia syndrome secondary to 5-fluorouracil therapy.

Authors:  G K Banfield; I D Crate; C L Griffiths
Journal:  J R Soc Med       Date:  1995-06       Impact factor: 5.344

5.  Prophylactic pyridoxine was not able to reduce the incidence of capecitabine-induced hand-foot syndrome: A meta-analysis.

Authors:  Yun Zhou; Ling Peng; Yingjie Li; Lixun Chen
Journal:  Biomed Rep       Date:  2013-08-28

6.  Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.

Authors:  Yoon-Sim Yap; Li-Lian Kwok; Nicholas Syn; Wen Yee Chay; John Whay Kuang Chia; Chee Kian Tham; Nan Soon Wong; Soo Kien Lo; Rebecca Alexandra Dent; Sili Tan; Zuan Yu Mok; King Xin Koh; Han Chong Toh; Wen Hsin Koo; Marie Loh; Raymond Chee Hui Ng; Su Pin Choo; Richie Chuan Teck Soong
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

7.  A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications.

Authors:  P G Corrie; R Bulusu; C B Wilson; G Armstrong; S Bond; R Hardy; S Lao-Sirieix; D Parashar; A Ahmad; F Daniel; M Hill; G Wilson; C Blesing; A M Moody; K McAdam; M Osborne
Journal:  Br J Cancer       Date:  2012-07-19       Impact factor: 7.640

8.  Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy.

Authors:  Hyun-Sook Son; Woo Yong Lee; Won-Suk Lee; Seong Hyeon Yun; Ho-Kyung Chun
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

Review 9.  Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review.

Authors:  Min Chen; Lingli Zhang; Qian Wang; Jiantong Shen
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.